Trial Profile
Phase I/II study of EVT 201 in a clinical model of insomnia in healthy adults
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Dimdazenil (Primary)
- Indications Insomnia
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors Evotec SE
- 05 Nov 2010 New trial record.